000			02176 a2200601 4500
005			20250517175307.0
264		0	_c20171229
008			201712s 0 0 eng d
022			_a1090-2163
024	7		_a10.1016/j.cellimm.2017.09.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcLeod, Jamie Josephine Avila
245	0	0	_aDidox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription. _h[electronic resource]
260			_bCellular immunology _cDec 2017
300			_a41-48 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcetylcysteine _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xpharmacology
650	0	4	_aAntioxidants _xpharmacology
650	0	4	_aBone Marrow Cells _ximmunology
650	0	4	_aCatalase _xbiosynthesis
650	0	4	_aCell Degranulation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aChemokine CCL3 _xbiosynthesis
650	0	4	_aHydroxamic Acids _xpharmacology
650	0	4	_aHypersensitivity _xdrug therapy
650	0	4	_aImmunoglobulin E _ximmunology
650	0	4	_aInterleukin-13 _xbiosynthesis
650	0	4	_aInterleukin-6 _xbiosynthesis
650	0	4	_aMast Cells _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNF-kappa B _xgenetics
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSuperoxide Dismutase _xbiosynthesis
650	0	4	_aTranscription Factor AP-1 _xgenetics
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aTumor Necrosis Factor-alpha _xbiosynthesis
700	1		_aCaslin, Heather L
700	1		_aSpence, Andrew J
700	1		_aKolawole, Elizabeth M
700	1		_aQayum, Amina Abdul
700	1		_aParanjape, Anuya
700	1		_aTaruselli, Marcela
700	1		_aHaque, Tamara T
700	1		_aKiwanuka, Kasalina N
700	1		_aElford, Howard L
700	1		_aRyan, John J
773	0		_tCellular immunology _gvol. 322 _gp. 41-48
856	4	0	_uhttps://doi.org/10.1016/j.cellimm.2017.09.008 _zAvailable from publisher's website
999			_c27618358 _d27618358